2021
DOI: 10.3906/sag-2106-59
|View full text |Cite
|
Sign up to set email alerts
|

Serum chitotriosidase and YKL-40 in acute pancreatitis: Reliability as prognostic marker for disease severity and correlation with inflammatory markers

Abstract: Background: Chitotriosidase and YKL-40, also called chitinase 3-like protein 1, are homologs of family 18 glycosyl hydrolases, secreted by human macrophages and granulocytes under inflammatory conditions. Although increased levels of chitotriosidase and YKL-40 are linked with several inflammatory diseases, the physiological utility of these two enzymes is still not fully characterized. This study aims to analyze the serum YKL-40 and chitotriosidase levels of acute pancreatitis patients to assess whether their … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 28 publications
0
1
0
Order By: Relevance
“…Thus, our findings add new and relevant proof to the growing body of evidence on the role of proinflammatory S100 proteins in AP patients with a prospect for potential diagnostic and therapeutic strategies At present, the severe form of AP is associated with an exceptionally high mortality rate rising to 30% due to rapid inflammatory development and complex pathophysiological conditions during the disease course (12,13). Therefore, there is an urgent and compelling need to determine the inflammatory status in AP patients especially in the very first days of hospital admission (14). In order to accomplish this goal and to determine the existence and the severity of pancreatic inflammation, clinical and biochemical evaluations are generally used in clinical practice (15).…”
Section: Discussionmentioning
confidence: 99%
“…Thus, our findings add new and relevant proof to the growing body of evidence on the role of proinflammatory S100 proteins in AP patients with a prospect for potential diagnostic and therapeutic strategies At present, the severe form of AP is associated with an exceptionally high mortality rate rising to 30% due to rapid inflammatory development and complex pathophysiological conditions during the disease course (12,13). Therefore, there is an urgent and compelling need to determine the inflammatory status in AP patients especially in the very first days of hospital admission (14). In order to accomplish this goal and to determine the existence and the severity of pancreatic inflammation, clinical and biochemical evaluations are generally used in clinical practice (15).…”
Section: Discussionmentioning
confidence: 99%